Scalese will report directly to chief executive officer Thomas Sandgaard.
Scalese has over 15 years of experience in accounting, finance and operations and has spent the past 13 years of his career in the high-tech and healthcare industries.
Scalese was recently chief financial officer at Qualmark, a publicly held global manufacturer of durability testing equipment.
Scalese joined Qualmark in February 2000 as corporate controller and also served as president for various subsidiaries of Qualmark and previously held positions at Coram Healthcare (now Apria Healthcare) as well as Foundation Health Systems.
Scalese’s previous experience includes public company reporting, merging and integrating companies, raising capital and divesting non-core businesses.
Zynex chief executive officer Thomas Sandgaard said that they are extremely pleased to have Anthony join Zynex as new CFO, as he brings a blend of financial and operational experience that they expect will benefit Zynex as we continue to execute growth strategy.
Zynex engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets – standard digital electrotherapy products for pain relief and pain management and the NeuroMovefor stroke and spinal cord injury rehabilitation.
